Praxis Precision Medicines
PRAX
PRAX
162 hedge funds and large institutions have $1.67B invested in Praxis Precision Medicines in 2024 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 55 increasing their positions, 52 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
22% more funds holding
Funds holding: 133 → 162 (+29)
10.31% more ownership
Funds ownership: 106.21% → 116.53% (+10%)
6% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 52
Holders
162
Holding in Top 10
7
Calls
$74.7M
Puts
$29.3M
Top Buyers
| 1 | +$83.3M | |
| 2 | +$63.4M | |
| 3 | +$42.2M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$31.3M |
| 5 |
VA
VR Adviser
New York
|
+$21.8M |
Top Sellers
| 1 | -$39.4M | |
| 2 | -$19.2M | |
| 3 | -$13.1M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$12M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$8.6M |